Navigation Links
Varian, Inc. Announces Cost Reduction Plan
Date:1/16/2009

PALO ALTO, Calif., Jan. 16 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) today announced a plan to eliminate approximately 240 regular employee and 80 temporary positions and to close certain facilities.

"In the face of continuing uncertainty in the global economic environment, we are taking proactive steps to reduce our cost structure, and position us to respond to demand fluctuations while continuing to invest in new product development and maintaining our high standard of customer service and support," said Garry W. Rogerson, President and Chief Executive Officer.

"We expect these actions will cost between $8.5 million and $10.5 million and result in a reduction of our annual operating expenses of between $20 million and $24 million once fully implemented. In addition to these restructuring actions, we have also instituted a salary freeze and restrictions on hiring and discretionary spending," said Rogerson. "Looking forward, these actions, combined with the positive impact of efficiency improvement activities implemented in recent years, should help us to maintain solid adjusted operating margins and cash flow from operations even if revenues decline. We will continue to monitor the economic situation and make the appropriate business decisions to remain successful throughout this challenging period, position ourselves for the economic recovery, and deliver on our long-term strategic plan."

Caution Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on management's current expectations, are not guarantees of future performance, and involve certain risks and uncertainties that could cause the company's actual results to differ materially from manage
'/>"/>

SOURCE Varian, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Varian, Inc. Announces Online Experience
2. Varian, Inc. CEO to Speak at the Nasdaq OMX 22nd Investor Program
3. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
4. New Flexible Vacuum Controller from Varian, Inc. is Expandable and Easy to Use
5. Varian, Inc. Board of Directors Makes Officer Changes
6. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
7. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
8. New Turbomolecular Pumping System From Varian, Inc. Delivers Portable, Dry, Ultra-high Vacuum.
9. Varian, Inc. Reports Third Quarter 2008 Results
10. James T. Glover Appointed to Board of Directors of Varian, Inc.
11. New Capillary Column From Varian, Inc. Offers Durability and Performance for High Temperature GC and GC/MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Corporation, an innovator of advanced optical instruments, announced ... with Harvard University granting Nikon the rights to ... Under the terms of the agreement, Nikon will ... with the N-STORM name. ,, Nikon Corporation ...
(Date:12/3/2009)... Calif., Dec. 3 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ... for the second quarter of fiscal year 2010 on December ... conference call and webcast to discuss the results at 11:30 ... will discuss financial results for the second quarter ended October ...
(Date:12/2/2009)... Biosciences Corporation (Nasdaq: MATK ) announced today that it ... fiscal year 2009 on December 16, 2009, at approximately 4:00 ... p.m. ET Martek will conduct a conference call to discuss ... to the call live via webcast by visiting Martek,s web ...
(Date:12/2/2009)... announces that a new market research report ... Drug Discovery Technologies - A Global Update ... http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ,, Drug discovery has ... every pharmaceutical company,s business strategy. There are ...
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
... today released its syndicated report TreatmentTrends ... fourth annual survey of U.S. Dermatologists (n=150). The report, ... highlights shifting trends in the management of psoriasis and psoriatic ... moderate, and severe patients with an emphasis on the evolving ...
... a research integrated,pharmaceutical Company (RIPCO), spun out from ... the decision of Merck Serono to no longer,invest ... advance promising,assets for cardio-metabolic diseases (with a primary ... 2 Clinical Proof-of-Concept, before,out-licensing these projects to major ...
... Stock Exchange Symbol: MSEDMONTON, May 28 /PRNewswire-FirstCall/ - BioMS Medical ... multiple sclerosis (MS), today announced that Mr. Randy Stroud, Vice ... Pharmaceutical Sciences 12th Annual Meeting & Symposium., ... Therapy for Multiple Sclerosis", WHEN: ...
Other Biology Technology:Raptiva Withdrawal Offers Upside for Enbrel and Humira According to Latest BioTrends Survey of U.S. Dermatologists 2Poxel SAS Set up to Find Innovative Solutions for Metabolic Diseases Management 2BioMS Medical to present at the 2009 Symposium for the Canadian Society for Pharmaceutical Sciences 2
(Date:12/3/2009)... occurred during the 2008-09 austral summer was likely due ... drivers, ENSO (El Nio - Southern Oscillation) and SAM ... Assistant Professor of Earth & Atmospheric Sciences at The ... Tedesco, who is also on the doctoral faculty at ...
(Date:12/2/2009)... PHILADELPHIA Less acculturated Latino men have a more ... acculturated to U.S. culture, but acculturation has no affect ... findings are published in Cancer Epidemiology, Biomarkers & ... Cancer Research. The December issue has a special focus ...
(Date:12/2/2009)... PHILADELPHIA Cigarette smoking and alcohol consumption before head ... risk of death, according to published studies. Now, results ... those who continued these habits after cancer diagnosis. , ... this, many still smoke. In our study, 21 percent ...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Acculturation affects smoking cessation success among Latinos 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Errors in diagnosis of depression lead to over and under diagnosis in primary care 53122 1Errors in diagnosis of depression lead to over and under diagnosis in primary care 53122 2New computer simulation helps explain folding in important cellular protein 9418 1New computer simulation helps explain folding in important cellular protein 9418 2New computer simulation helps explain folding in important cellular protein 9418 3Health benefits of physical activity more pronounced in women 9413 1Health benefits of physical activity more pronounced in women 9413 2
... The Biophysical Society has announced the winner of its ... of the Biophysical Society and the International Biophysics Congress ... awards are meant to encourage participation at the Biophysical ... Recipients will be honored at a reception on ...
... Spanish . , Idiopathic pulmonary fibrosis is a disease ... it is already in an advanced stage. Patients suffering from ... a very reduced quality of life. Because of lack of ... diagnosed. Idiopathic pulmonary fibrosis affects 13 out of 100,000 men ...
... focuses on: , , The evolution of hydroecology/ecohydrology ... linkages , Methological approaches , Detailed case studies ... considers a range of organisms (plants, invertebrates and ... palaeosystems, and emphasizes wider research implications with respect ...
Other Biology News:Biophysical Society announces winners of 2008 Minority Travel Awards 2Translational research patented first experimental treatment against idiopathic pulmonary fibrosis 2
The imaging screen-K (Kodak), is a 35 x 43 cm storage phosphor screen that is used for the quantitation and imaging of 32P, 33P, 35S, 14C, and 3H....
The external laser upgrade for the Molecular Imager FX adds a 635 nm external laser; the 555 nm long pass filter is replaced with a 605 nm band pass filter to distinguish Cy5 from 532 nm excitable dy...
The HQ505, 20 OptiGreen filter for the Molecular Imager FX is a band pass filter used for detection of Cy2 and FITC with 532 nm excitation....
The filter 605DF50 for the Molecular Imager FX is a band pass filter for ethidium bromide, SYPRO Red, SYPRO Ruby, Alexa Fluor 532 and 546, and Cy3 dyes when using the 635 nm laser....
Biology Products: